Also, T cells in the ILT4 knockdown group rather than in the PD-L1 blockade or combination therapy group displayed increased IFN-γ levels in blood, spleens and tumor tissues compared with the control group (Figure 7H-I). This evidence concerns the gene LILRB2 and neoplasm.